✦ LIBER ✦

P-469 Weekly paclitaxel (P), carboplatin (C) and innotecan (I), PCI, in patients with chemo-naive advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Chang, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly treatment of non-small-cell lung

✍ Schroeder, M.; Ukena, D.; Schütte, W.; Schröder, R.; Westerhausen, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Phase I study of paclitaxel, carboplatin

✍ Yasushi Ono; Mitsunori Hino; Yuka Ueda; Ryoko Kamizuru; Masatoshi Omata; Takashi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 123 KB

Paclitaxel (P) plus carboplatin (C) in a

✍ Richardet, E; Cóppola, F; Jovtis, S; Fein, L; Uranga, G; Lewi, D; Ventriglia, M; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 260 KB

Second-line (SL) weekly paclitaxel (P) i

✍ Socinski, M.A; Kies, M; Unger, P; Peterman, A; Gillenwater, H.H; Schell, M; Bakr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 231 KB

P-15 A phaseII study of bi-weekly paclit

✍ Kashii, Tatsuhiko; Kasahara, Kazuo; Nishi, Koichi; Kita, Toshiyuki; Oda, Hirofum 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

P-493 A phase II study of weekly innotec

✍ Han, J.; Lee, D.; Lee, S.; Park, C.; Kim, H.; Lee, H.; Lee, J.; Lee, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB